One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-110562
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
Affiliation: Willamette Valley Cancer Institute and Research Center, Hofstra University, Duke University Health System, Swedish Medical Center, Lymphoma Research Foundation, Tufts Medical Center, CancerCare, Levine Cancer Institute, Pharmacyclics (United States), AbbVie (United States), Janssen (United States), Memorial Sloan Kettering Cancer CenterChronic Lymphocytic Leukemia Treatment Patterns, Dosing, and Sequencing in the Era of Novel Targeted Therapies: Interim Analysis Results from the Prospective informCLLTM Real-World Registry
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
